[The value of etoposide (VP-16) in the therapy of refractory ovarian cancer]. [electronic resource]
Producer: 19930720Description: 303-7 p. digitalISSN:- 0016-5751
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Biomarkers, Tumor -- blood
- Cause of Death
- Cystadenocarcinoma -- drug therapy
- Dose-Response Relationship, Drug
- Etoposide -- administration & dosage
- Female
- Humans
- Leukemia, Monocytic, Acute -- chemically induced
- Middle Aged
- Neoplasm Recurrence, Local -- drug therapy
- Neoplasm Staging
- Ovarian Neoplasms -- drug therapy
- Precursor B-Cell Lymphoblastic Leukemia-Lymphoma -- chemically induced
- Survival Rate
No physical items for this record
Publication Type: English Abstract; Journal Article
There are no comments on this title.
Log in to your account to post a comment.